Contact Us
Menu
Effective Evidence

Inherited Conditions

Cystic Fibrosis

Pink J, Colquitt J, Melendez-Torres GJ et al. Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation. A Single Technology Appraisal. 2016

Duchenne muscular dystrophy

Auguste P, Colquitt J, Freeman K et al. Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene. A Highly specialised technology. 2016

Back to main publications page

Latest Publications

Surgery for early structural osteoarthritis of the hip and knee: the SCORE evidence synthesis and economic evaluation

Rapid tests to inform triage and antibiotic prescribing decisions for adults presenting with suspected acute respiratory infection: a rapid evidence synthesis of clinical effectiveness and cost-utility studies

Artificial intelligence software for analysing chest X-ray images to identify suspected lung cancer: an evidence synthesis early value assessment

Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy

 

 

 

 

 

 

Latest Publications

© Effective Evidence LLP 2021.  Company No. OC397711. Privacy Policy

Website by Harris Digital Web Design